Clinical Trial Update: Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating aficamten versus metoprolol succinate in adults with symptomatic obstructive hypertrophic cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• Aficamten (aficamten)
• Metoprolol succinate (METOPROLOL SUCCINATE)

Snippet

Sponsor: Cytokinetics | Conditions: Obstructive Hypertrophic Cardiomyopathy (oHCM) | Phase 3 | Status: COMPLETED